http://www.biotechnologynews.net/storyview.asp?storyid=1026042§ionsource=s0&highlight=%NOVOGEN%
MORE NEWS!
NOVOGEN dumps phase 3 trial of "OVERTURE" Ovarian cancer therapy ( oral )on April 14th. Pure coincidence? I dont think so.
Adds substantial weight to the PRR technology efficacy me thinks!. Those in the know ( industry ) know!
The only question is how will PRR's management handle the new leverage coming thier way
http://www.biotechnologynews.net/storyview.asp?storyid=1026042&se...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |